Post Categories
QPS COVID-19 Testing Capabilities
November 11, 2020
The COVID-19 pandemic has been a call to arms for many of the world’s biotech and pharmaceutical companies. Although progress has been made, these…
Gene Therapy and Inherited Retinal Diseases
November 9, 2020
Inherited retinal diseases (IRDs) can cause vision loss that ranges from mild to severe, and can even cause blindness. These diseases affect people of…
Oligonucleotides: Innovations in Antivirals for Novel Viruses
November 2, 2020
As scientists, doctors and researchers race to develop vaccines and therapeutics for SARS-CoV-2, several drugs have emerged as promising candidates. Oligonucleotide therapeutics are one…
UK COVID-19 Challenge Trials to Infect Healthy Volunteers with Coronavirus
October 29, 2020
As communities strive to prevent the spread of SARS-CoV-2, the virus that causes COVID-19, the United Kingdom is funding research trials that will deliberately…
Animals and the COVID-19 Pandemic: Contributions and Risks
October 19, 2020
Global cases of the novel coronavirus have surpassed thirty-seven million, and the global fatality count is now more than one million. Most media and…
23andMe Data Bolsters Link Between COVID-19 and Blood Types
October 12, 2020
Did you know that a person’s blood type may be linked to the likelihood that they will catch COVID-19 and experience severe symptoms? Recently 23andMe,…
COVID-19 versus the Seasonal Flu: Facts and Figures
October 5, 2020
Since SARS-CoV-2 (or the novel coronavirus, the virus that causes COVID-19) emerged, many have compared it to the seasonal flu. The seasonal flu virus…
Marmosets as Primate Models of Familial Alzheimer’s Disease
September 28, 2020
The common marmoset, Callithrix jaccus, possesses complex social behaviors and sleep patterns that closely resemble those of humans. This South American monkey’s metabolism, immune…
U.S. Plans to Offer Free COVID-19 Vaccines to All Americans
September 23, 2020
On Wednesday, September 16, 2020, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) released two documents outlining the…
The Latest in Weird & Whimsical Science: Part II
September 21, 2020
The QPS blog focuses on presenting our insights into news on topics that are highly relevant to the pharmaceutical, biotech and CRO industries such…
The Latest in Weird & Whimsical Science: Part I
September 14, 2020
The QPS blog focuses on presenting news about topics such as Alzheimer’s Disease, COVID-19, and clinical research to our clients and the public. This…
Amodiaquine: Learning from the Hydroxychloroquine Mistake
September 8, 2020
Both the scientific community and the general public now know that hydroxychloroquine is ineffective against SARS-CoV-2, the virus that causes COVID-19. The FDA revoked…
The Gut-Brain Connection in Alzheimer’s Disease
March 27, 2023
Neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease, are often associated with the build-up of cellular debris, like misfolded proteins, within the…
Can We Reverse Aging by Targeting Old Cells?
March 22, 2023
James Kirkland and Tamara Tchkonia, researchers at the Mayo Clinic, are at the forefront of a movement focused on stopping chronic disease by targeting…
Harnessing the Power of Monoclonal Antibodies in the Fight Against Malaria
March 20, 2023
Monoclonal antibodies have been deployed to treat a variety of diseases, from cancer to COVID-19. Now this treatment approach, which doesn’t depend on the…
First Vaccine for Honeybees Prevents American Foulbrood
March 15, 2023
A healthy honeybee population is a critical component of healthy ecosystems, clean air, and stable soil. Honeybees also play a critical role in food…
Precision Steering of CAR-T Therapies May Effectively Target More Tumor Types
March 13, 2023
Recent years have seen increased research interest in the potential of chimeric antigen receptor (CAR)-T cancer therapies. This approach uses genetic engineering to modify…
First Malaria Vaccine Is a Milestone Achievement and Poses a Manufacturing Challenge
March 6, 2023
Following 30 years of research and development, the first malaria vaccine was recommended by the World Health Organization (WHO) for widespread use in children…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
